An update on clonality: What smooth muscle cell type makes up the atherosclerotic plaque?.

F1000Research

Volumn 7, Issue , 2018, Pages

  Schwartz, Stephen M ^a   Virmani, Renu ^b   Majesky, Mark W ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CVPATH INSTITUTE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Cancer; Clonality; Developmental biology; Endothelium; Fibroblast; Intimal hyperpasia; Mesoderm; Myofibroblast; Neoplastia; Pericyte; Smooth muscle cells; Somatic mosaicism; Vascular biology

Indexed keywords

ARTERY MEDIA; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; CLONAL VARIATION; ENDOTHELIUM CELL; EPIGENETICS; FIBROBLAST; HEREDITY; HUMAN; HYPERLIPIDEMIA; IMMUNE SYSTEM; LIPID STORAGE; MOSAICISM; MYOFIBROBLAST; NEOINTIMA; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; PHENOTYPE; REVIEW; SMOOTH MUSCLE CELL; STEM CELL; ANIMAL; CELL CLONE; INTIMA; PATHOLOGY; TUNICA MEDIA;

ANIMALS; CLONE CELLS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; TUNICA INTIMA; TUNICA MEDIA;

EID: 85059503030     PISSN: None     EISSN: 20461402     Source Type: Journal    
DOI: 10.12688/f1000research.15994.1     Document Type: Review

References (320)

1. Benditt EP: Evidence for a monoclonal origin of human atherosclerotic plaques and some implications. Circulation. 1974; 50(4): 650-2. PubMed Abstract | Publisher Full Text
2. Chung IM, Schwartz SM, Murry CE: Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am J Pathol. 1998; 152(4): 913-23. PubMed Abstract | Free Full Text
3. Gomez D, Owens GK: Reconciling Smooth Muscle Cell Oligoclonality and Proliferative Capacity in Experimental Atherosclerosis. Circ Res. 2016; 119(12): 1262-4. PubMed Abstract | Publisher Full Text | Free Full Text
4. Ikari Y, McManus BM, Kenyon J, et al.: Neonatal intima formation in the human coronary artery. Arterioscler Thromb Vasc Biol. 1999; 19(9): 2036-40. PubMed Abstract | Publisher Full Text
5. Murry CE, Gipaya CT, Bartosek T, et al.: Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol. 1997; 151(3): 697-705. PubMed Abstract | Free Full Text
6. Pearson TA, Dillman JM, Heptinstall RH: Clonal mapping of the human aorta. Relationship of monoclonal characteristics, lesion thickness, and age in normal intima and atherosclerotic lesions. Am J Pathol. 1987; 126(1): 33-9. PubMed Abstract | Free Full Text
7. Thomas WA, Lee KT, Kim DN: Cell population kinetics in atherogenesis. Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine. Ann N Y Acad Sci. 1985; 454: 305-15. PubMed Abstract | Publisher Full Text
8. Bentzon JF, Majesky MW: Lineage tracking of origin and fate of smooth muscle cells in atherosclerosis. Cardiovasc Res. 2018; 114(4): 492-500. PubMed Abstract | Publisher Full Text | Free Full Text
9. DiRenzo D, Owens GK, Leeper NJ: “Attack of the Clones”: Commonalities Between Cancer and Atherosclerosis. Circ Res. 2017; 120(4): 624-6. PubMed Abstract | Publisher Full Text | Free Full Text
10. Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973; 70(6): 1753-6. PubMed Abstract | Publisher Full Text | Free Full Text
11. Moss NS, Benditt EP: Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol. 1975; 78(2): 175-90. PubMed Abstract | Free Full Text
12. Commandeur AE, Styer AK, Teixeira JM: Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015; 21(5): 593-615. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
13. Dal Cin P, Moerman P, Deprest J, et al.: A new cytogenetic subgroup in uterine leiomyoma is characterized by a deletion of the long arm of chromosome 3. Genes Chromosomes Cancer. 1995; 13(3): 219-20. PubMed Abstract | Publisher Full Text
14. Fejzo MS, Yoon SJ, Montgomery KT, et al.: Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics. 1995; 26(2): 265-71. PubMed Abstract | Publisher Full Text
15. Hashimoto K, Azuma C, Kamiura S, et al.: Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest. 1995; 40(3): 204-8. PubMed Abstract | Publisher Full Text
16. Hayashi S, Miharu N, Okamoto E, et al.: Detection of chromosomal abnormalities of chromosome 12 in uterine leiomyoma using fluorescence in situ hybridization. Jpn J Hum Genet. 1996; 41(1): 193-202. PubMed Abstract | Publisher Full Text
17. Hug K, Doney MK, Tyler MJ, et al.: Physical mapping of the uterine leiomyoma t(12;14)(q13-15;q24.1) breakpoint on chromosome 14 between SPTB and D14S77. Genes Chromosomes Cancer. 1994; 11(4): 263-6. PubMed Abstract | Publisher Full Text
18. Nilbert M, Heim S, Mandahl N, et al.: Trisomy 12 in uterine leiomyomas. A new cytogenetic subgroup. Cancer Genet Cytogenet. 1990; 45(1): 63-6. PubMed Abstract | Publisher Full Text
19. Vanni R, Lecca U, Faa G: Uterine leiomyoma cytogenetics. II. Report of forty cases. Cancer Genet Cytogenet. 1991; 53(2): 247-56. PubMed Abstract | Publisher Full Text
20. Williams AJ, Powell WL, Collins T, et al.: HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol. 1997; 150(3): 911-8. PubMed Abstract | Free Full Text
21. Majesky MW, Reidy MA, Benditt EP, et al.: Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci U S A. 1985; 82(10): 3450-4. PubMed Abstract | Publisher Full Text | Free Full Text
22. Schwartz SM, Galis ZS, Rosenfeld ME, et al.: Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007; 27(4): 705-13. PubMed Abstract | Publisher Full Text
23. Yang X, Peterson L, Thieringer R, et al.: Identification and validation of genes affecting aortic lesions in mice. J Clin Invest. 2010; 120(7): 2414-22. PubMed Abstract | Publisher Full Text | Free Full Text
24. Stary HC: Macrophage foam cells in the coronary artery intima of human infants. Ann N Y Acad Sci. 1985; 454: 5-8. PubMed Abstract | Publisher Full Text
25. Yurovsky VV, Sutton PA, Schulze DH, et al.: Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients. J Immunol. 1994; 153(2): 881-91. PubMed Abstract
26. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1993; 13(9): 1291-8. PubMed Abstract | Publisher Full Text
27. Stary HC, Chandler AB, Dinsmore RE, et al.: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995; 15(9): 1512-31. PubMed Abstract | Publisher Full Text
28. Stary HC, Chandler AB, Glagov S, et al.: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994; 89(5): 2462-78. PubMed Abstract | Publisher Full Text
29. DeBakey ME, Glaeser DH: Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up. Am J Cardiol. 2000; 85(9): 1045-53. PubMed Abstract | Publisher Full Text
30. Virchow R: Cellular Pathology as Based Upon Physiological and Pathological Histology. Birmingham, Alabama: Classics of Medicine Library. 1858; 2. Reference Source
31. Ross R: Mechanisms of atherosclerosis--a review. Adv Nephrol Necker Hosp. 1990; 19: 79-86. PubMed Abstract
32. Getz GS, Reardon CA: Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(5): 1104-15. PubMed Abstract | Publisher Full Text | Free Full Text
33. Getz GS, Reardon CA: Use of Mouse Models in Atherosclerosis Research. Methods Mol Biol. 2015; 1339: 1-16. PubMed Abstract | Publisher Full Text
34. Kaplan JR, Chen H, Manuck SB: The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta-analysis. Am J Primatol. 2009; 71(9): 732-41. PubMed Abstract | Publisher Full Text | Free Full Text
35. Lusis AJ, Weiss JN: Cardiovascular networks: systems-based approaches to cardiovascular disease. Circulation. 2010; 121(1): 157-70. PubMed Abstract | Publisher Full Text | Free Full Text
36. Lusis AJ: Atherosclerosis. Nature. 2000; 407(6801): 233-41. PubMed Abstract | Publisher Full Text | Free Full Text
37. Ross R: Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am J Pathol. 1993; 143(4): 987-1002. PubMed Abstract | Free Full Text
38. Sheth SS, Deluna A, Allayee H, et al.: Understanding atherosclerosis through mouse genetics. Curr Opin Lipidol. 2002; 13(2): 181-9. PubMed Abstract | Publisher Full Text
39. Shih DM, Welch C, Lusis AJ: New insights into atherosclerosis from studies with mouse models. Mol Med Today. 1995; 1(8): 364-72. PubMed Abstract | Publisher Full Text
40. Wang SS, Schadt EE, Wang H, et al.: Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res. 2007; 101(3): e11-30. PubMed Abstract | Publisher Full Text
41. Wu S, Lusis AJ, Drake TA: A systems-based framework for understanding complex metabolic and cardiovascular disorders. J Lipid Res. 2009; 50(Suppl): S358-63. PubMed Abstract | Publisher Full Text | Free Full Text
42. Schwartz SM: The intima: A new soil. Circ Res. 1999; 85(10): 877-9. PubMed Abstract
43. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res. 1995; 77(3): 445-65. PubMed Abstract | Publisher Full Text
44. Glass CK, Witztum JL: Atherosclerosis. the road ahead. Cell. 2001; 104(4): 503-16. PubMed Abstract | Publisher Full Text
45. Jacobsen K, Lund MB, Shim J, et al.: Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs. JCI Insight. 2017; 2(19): pii: 95890. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
46. Bennett MR, Sinha S, Owens GK: Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res. 2016; 118(4): 692-702. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
47. Bentzon JF, Sondergaard CS, Kassem M, et al.: Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation. 2007; 116(18): 2053-61. PubMed Abstract | Publisher Full Text
48. Chappell J, Harman JL, Narasimhan VM, et al.: Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models. Circ Res. 2016; 119(12): 1313-23. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
49. Mazurek R, Dave JM, Chandran RR, et al.: Vascular Cells in Blood Vessel Wall Development and Disease. Adv Pharmacol. 2017; 78: 323-50. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
50. Misra A, Feng Z, Chandran RR, et al.: Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells. Nat Commun. 2018; 9(1): 2073. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
51. Cybulsky MI, Won D, Haidari M: Leukocyte recruitment to atherosclerotic lesions. Can J Cardiol. 2004; 20(Suppl B): 24B-28B. PubMed Abstract
52. Rong JX, Shapiro M, Trogan E, et al.: Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci U S A. 2003; 100(23): 13531-6. PubMed Abstract | Publisher Full Text | Free Full Text
53. Shankman LS, Gomez D, Cherepanova OA, et al.: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015; 21(6): 628-37. PubMed Abstract | Publisher Full Text | Free Full Text
54. Shankman LS, Gomez D, Cherepanova OA, et al.: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015; 21(6): 628-37. PubMed Abstract | Publisher Full Text | Free Full Text
55. Vengrenyuk Y, Nishi H, Long X, et al.: Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol. 2015; 35(3): 535-46. PubMed Abstract | Publisher Full Text | Free Full Text
56. Vanlandewijck M, He L, Mäe MA, et al.: A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018; 554(7693): 475-80. PubMed Abstract | Publisher Full Text | F1000 Recommendation
57. Bargehr J, Low L, Cheung C, et al.: Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation. Stem Cells Transl Med. 2016; 5(7): 946-59. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
58. Majesky MW: Developmental biology in the vasculature--review series. Arterioscler Thromb Vasc Biol. 2009; 29(5): 622. PubMed Abstract | Publisher Full Text
59. Majesky MW: Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol. 2007; 27(6): 1248-58. PubMed Abstract | Publisher Full Text
60. Sinha S, Iyer D, Granata A: Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell Mol Life Sci. 2014; 71(12): 2271-88. PubMed Abstract | Publisher Full Text | Free Full Text
61. Sinha S, Santoro MM: New models to study vascular mural cell embryonic origin: implications in vascular diseases. Cardiovasc Res. 2018; 114(4): 481-91. PubMed Abstract | Publisher Full Text | F1000 Recommendation
62. Feil S, Hofmann F, Feil R: SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res. 2004; 94(7): 863-5. PubMed Abstract | Publisher Full Text
63. Wamhoff BR, Hoofnagle MH, Burns A, et al.: A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res. 2004; 95(10): 981-8. PubMed Abstract | Publisher Full Text
64. Firulli AB, Han D, Kelly-Roloff L, et al.: A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell Dev Biol Anim. 1998; 34(3): 217-26. PubMed Abstract | Publisher Full Text
65. Akyürek LM, Yang ZY, Aoki K, et al.: SM22alpha promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo. Mol Med. 2000; 6(11): 983-91. PubMed Abstract | Publisher Full Text | Free Full Text
66. Albinsson S, Skoura A, Yu J, et al.: Smooth muscle miRNAs are critical for postnatal regulation of blood pressure and vascular function. PLoS One. 2011; 6(4): e18869. PubMed Abstract | Publisher Full Text | Free Full Text
67. Bär H, Wende P, Watson L, et al.: Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res Cardiol. 2002; 97(1): 9-16. PubMed Abstract | Publisher Full Text
68. Cai WJ, Kocsis E, Scholz D, et al.: Presence of Cx37 and lack of desmin in smooth muscle cells are early markers for arteriogenesis. Mol Cell Biochem. 2004; 262(1-2): 17-23. PubMed Abstract | Publisher Full Text
69. Camoretti-Mercado B, Liu HW, Halayko AJ, et al.: Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem. 2000; 275(39): 30387-93. PubMed Abstract | Publisher Full Text
70. + stem cells in mural cell formation in the human choroid: evidence of vascular instability due to limited pericyte ensheathment. Invest Ophthalmol Vis Sci. 2011; 52(1): 399-410. PubMed Abstract | Publisher Full Text
71. Duband JL, Gimona M, Scatena M, et al.: Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation. 1993; 55(1): 1-11. PubMed Abstract | Publisher Full Text
72. Frid MG, Moiseeva EP, Stenmark KR: Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res. 1994; 75(4): 669-81. PubMed Abstract | Publisher Full Text
73. Frid MG, Shekhonin BV, Koteliansky VE, et al.: Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol. 1992; 153(2): 185-93. PubMed Abstract | Publisher Full Text
74. Gabbiani G, Kocher O, Bloom WS, et al.: Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 1984; 73(1): 148-52. PubMed Abstract | Publisher Full Text | Free Full Text
75. Galmiche MC, Koteliansky VE, Brière J, et al.: Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 1993; 82(1): 66-76. PubMed Abstract
76. Gröschel-Stewart U, Chamley JH, McConnell JD, et al.: Comparison of the reaction of cultured smooth and cardiac muscle cells and fibroblasts to specific antibodies to myosin. Histochemistry. 1975; 43(3): 215-24. PubMed Abstract | Publisher Full Text
77. Johansson B, Eriksson A, Ramaekers F, et al.: Smoothelin in adult and developing human arteries and myocardium. Histochem Cell Biol. 1999; 112(4): 291-9. PubMed Abstract | Publisher Full Text
78. Johansson B, Eriksson A, Ramaekers F, et al.: Smoothelin and intermediate filament proteins in human aortocoronary saphenous vein by-pass grafts. Histochem J. 1999; 31(11): 723-7. PubMed Abstract | Publisher Full Text
79. Kacem K, Seylaz J, Aubineau P: Differential processes of vascular smooth muscle cell differentiation within elastic and muscular arteries of rats and rabbits: an immunofluorescence study of desmin and vimentin distribution. Histochem J. 1996; 28(1): 53-61. PubMed Abstract | Publisher Full Text
80. Kaplan-Albuquerque N, Garat C, Van Putten V, et al.: Regulation of SM22 alpha expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003; 285(4): H1444-52. PubMed Abstract | Publisher Full Text
81. Ko YS, Coppen SR, Dupont E, et al.: Regional differentiation of desmin, connexin43, and connexin45 expression patterns in rat aortic smooth muscle. Arterioscler Thromb Vasc Biol. 2001; 21(3): 355-64. PubMed Abstract | Publisher Full Text
82. Ko YS, Yeh HI, Haw M, et al.: Differential expression of connexin43 and desmin defines two subpopulations of medial smooth muscle cells in the human internal mammary artery. Arterioscler Thromb Vasc Biol. 1999; 19(7): 1669-80. PubMed Abstract | Publisher Full Text
83. Kolodziejska KM, Noyan-Ashraf MH, Nagy A, et al.: c-Myb-dependent smooth muscle cell differentiation. Circ Res. 2008; 102(5): 554-61. PubMed Abstract | Publisher Full Text
84. Landerholm TE, Dong XR, Lu J, et al.: A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development. 1999; 126(10): 2053-62. PubMed Abstract
85. Lees-Miller JP, Heeley DH, Smillie LB: An abundant and novel protein of 22 kDa (SM22) is widely distributed in smooth muscles. Purification from bovine aorta. Biochem J. 1987; 244(3): 705-9. PubMed Abstract | Publisher Full Text | Free Full Text
86. Li L, Miano JM, Mercer B, et al.: Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol. 1996; 132(5): 849-59. PubMed Abstract | Publisher Full Text | Free Full Text
87. Li ZL, Lilienbaum A, Butler-Browne G, et al.: Human desmin-coding gene: complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene. 1989; 78(2): 243-54. PubMed Abstract | Publisher Full Text
88. Mack CP, Somlyo AV, Hautmann M, et al.: Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 2001; 276(1): 341-7. PubMed Abstract | Publisher Full Text
89. Mericskay M, Li Z, Paulin D: Transcriptional regulation of the desmin and SM22 genes in vascular smooth muscle cells. Curr Top Pathol. 1999; 93: 7-17. PubMed Abstract | Publisher Full Text
90. Miano JM, Cserjesi P, Ligon KL, et al.: Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994; 75(5): 803-12. PubMed Abstract | Publisher Full Text
91. Miano JM, Olson EN: Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem. 1996; 271(12): 7095-103. PubMed Abstract | Publisher Full Text
92. Moessler H, Mericskay M, Li Z, et al.: The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development. 1996; 122(8): 2415-25. PubMed Abstract
93. Rensen SS, Thijssen VL, De Vries CJ, et al.: Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res. 2002; 55(4): 850-63. PubMed Abstract | Publisher Full Text
94. Ruzicka DL, Schwartz RJ: Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation. J Cell Biol. 1988; 107(6 Pt 2): 2575-86. PubMed Abstract | Publisher Full Text | Free Full Text
95. Samaha FF, Ip HS, Morrisey EE, et al.: Developmental pattern of expression and genomic organization of the calponin-h1 gene. A contractile smooth muscle cell marker. J Biol Chem. 1996; 271(1): 395-403. PubMed Abstract | Publisher Full Text
96. Sjuve R, Arner A, Li Z, et al.: Mechanical alterations in smooth muscle from mice lacking desmin. J Muscle Res Cell Motil. 1998; 19(4): 415-29. PubMed Abstract | Publisher Full Text
97. Skalli O, Gabbiani F, Gabbiani G: Action of general and alpha-smooth muscle-specific actin antibody microinjection on stress fibers of cultured smooth muscle cells. Exp Cell Res. 1990; 187(1): 119-25. PubMed Abstract | Publisher Full Text
98. Skalli O, Ropraz P, Trzeciak A, et al.: A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986; 103(6 Pt 2): 2787-96. PubMed Abstract | Publisher Full Text | Free Full Text
99. Sobue K, Hayashi K, Nishida W: Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 1999; 190(1-2): 105-18. PubMed Abstract | Publisher Full Text
100. Solway J, Seltzer J, Samaha FF, et al.: Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem. 1995; 270(22): 13460-9. PubMed Abstract | Publisher Full Text
101. Takahashi K, Hiwada K, Kokubu T: Vascular smooth muscle calponin. A novel troponin T-like protein. Hypertension. 1988; 11(6 Pt 2): 620-6. PubMed Abstract | Publisher Full Text
102. van der Loop FT, Gabbiani G, Kohnen G, et al.: Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol. 1997; 17(4): 665-71. PubMed Abstract | Publisher Full Text
103. van Eys GJ, Völler MC, Timmer ED, et al.: Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct. 1997; 22(1): 65-72. PubMed Abstract | Publisher Full Text
104. Wehrens XH, Mies B, Gimona M, et al.: Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform. FEBS Lett. 1997; 405(3): 315-20. PubMed Abstract | Publisher Full Text
105. 13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med. 2008; 14(1): 64-8. PubMed Abstract | Publisher Full Text | F1000 Recommendation
106. Wu SP, Dong XR, Regan JN, et al.: Tbx18 regulates development of the epicardium and coronary vessels. Dev Biol. 2013; 383(2): 307-20. PubMed Abstract | Publisher Full Text | Free Full Text
107. Xu R, Ho YS, Ritchie RP, et al.: Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages. Am J Physiol Heart Circ Physiol. 2003; 284(4): H1398-407. PubMed Abstract | Publisher Full Text
108. Yablonka-Reuveni Z, Christ B, Benson JM: Transitions in cell organization and in expression of contractile and extracellular matrix proteins during development of chicken aortic smooth muscle: evidence for a complex spatial and temporal differentiation program. Anat Embryol (Berl). 1998; 197(6): 421-37. PubMed Abstract | Publisher Full Text | Free Full Text
109. Zhang JC, Kim S, Helmke BP, et al.: Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol. 2001; 21(4): 1336-44. PubMed Abstract | Publisher Full Text | Free Full Text
110. Zohlnhöfer D, Klein CA, Richter T, et al.: Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation. 2001; 103(10): 1396-402. PubMed Abstract | Publisher Full Text
111. Andrews A, Balciunaite E, Leong FL, et al.: Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1999; 40(11): 2683-9. PubMed Abstract
112. Armulik A, Genové G, Betsholtz C: Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011; 21(2): 193-215. PubMed Abstract | Publisher Full Text | F1000 Recommendation
113. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 1998; 125(9): 1591-8. PubMed Abstract | F1000 Recommendation
114. Berger M, Bergers G, Arnold B, et al.: Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 2005; 105(3): 1094-101. PubMed Abstract | Publisher Full Text
115. Bondjers C, He L, Takemoto M, et al.: Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes. FASEB J. 2006; 20(10): 1703-5. PubMed Abstract | Publisher Full Text
116. Bondjers C, Kalén M, Hellström M, et al.: Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol. 2003; 162(3): 721-9. PubMed Abstract | Publisher Full Text | Free Full Text
117. Chen YT, Chang FC, Wu CF, et al.: Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 2011; 80(11): 1170-81. PubMed Abstract | Publisher Full Text
118. Cho H, Kozasa T, Bondjers C, et al.: Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J. 2003; 17(3): 440-2. PubMed Abstract | Publisher Full Text
119. Cho H, Park C, Hwang IY, et al.: Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol. 2008; 28(8): 2590-7. PubMed Abstract | Publisher Full Text | Free Full Text
120. Crisan M, Yap S, Casteilla L, et al.: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3(3): 301-13. PubMed Abstract | Publisher Full Text | F1000 Recommendation
121. Dhar K, Dhar G, Majumder M, et al.: Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1. Mol Cancer. 2010; 9: 209. PubMed Abstract | Publisher Full Text | Free Full Text
122. Hellström M, Gerhardt H, Kalén M, et al.: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol. 2001; 153(3): 543-53. PubMed Abstract | Publisher Full Text | Free Full Text
123. Herman IM, D'Amore PA: Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol. 1985; 101(1): 43-52. PubMed Abstract | Publisher Full Text | Free Full Text
124. Howson KM, Aplin AC, Gelati M, et al.: The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol. 2005; 289(6): C1396-407. PubMed Abstract | Publisher Full Text
125. Mitchell TS, Bradley J, Robinson GS, et al.: RGS5 expression is a quantitative measure of pericyte coverage of blood vessels. Angiogenesis. 2008; 11(2): 141-51. PubMed Abstract | Publisher Full Text
126. Ozerdem U, Grako KA, Dahlin-Huppe K, et al.: NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn. 2001; 222(2): 218-27. PubMed Abstract | Publisher Full Text
127. Schrimpf C, Duffield JS: Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens. 2011; 20(3): 297-305. PubMed Abstract | Publisher Full Text
128. Moore-Morris T, Tallquist MD, Evans SM: Sorting out where fibroblasts come from. Circ Res. 2014; 115(7): 602-4. PubMed Abstract | Publisher Full Text | Free Full Text
129. Snider P, Hinton RB, Moreno-Rodriguez RA, et al.: Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res. 2008; 102(7): 752-60. PubMed Abstract | Publisher Full Text | Free Full Text
130. Denton CP, Zheng B, Shiwen X, et al.: Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice. Arthritis Rheum. 2001; 44(3): 712-22. PubMed Abstract | Publisher Full Text
131. Gebhard S, Hattori T, Bauer E, et al.: Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter. Matrix Biol. 2008; 27(8): 693-9. PubMed Abstract | Publisher Full Text | Free Full Text
132. Iwano M, Fischer A, Okada H, et al.: Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther. 2001; 3(2): 149-59. PubMed Abstract | Publisher Full Text
133. Niederreither K, D'Souza RN, de Crombrugghe B: Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice. J Cell Biol. 1992; 119(5): 1361-70. PubMed Abstract | Publisher Full Text | Free Full Text
134. Soundararajan M, Kannan S: Fibroblasts and mesenchymal stem cells: Two sides of the same coin? J Cell Physiol. 2018; 233(12): 9099-109. PubMed Abstract | Publisher Full Text
135. Wu J, Montaniel KR, Saleh MA, et al.: Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension. 2016; 67(2): 461-8. PubMed Abstract | Publisher Full Text | Free Full Text
136. Hu Y, Zhang Z, Torsney E, et al.: Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004; 113(9): 1258-65. PubMed Abstract | Publisher Full Text | Free Full Text
137. Passman JN, Dong XR, Wu SP, et al.: A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci U S A. 2008; 105(27): 9349-54. PubMed Abstract | Publisher Full Text | Free Full Text
138. Harhun MI, Pucovský V, Povstyan OV, et al.: Interstitial cells in the vasculature. J Cell Mol Med. 2005; 9(2): 232-43. PubMed Abstract | Publisher Full Text
139. Hibbert B, Chen YX, O'Brien ER: c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol. 2004; 287(2): H518-24. PubMed Abstract | Publisher Full Text
140. Kramann R, Schneider RK, DiRocco DP, et al.: Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015; 16(1): 51-66. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
141. Zengin E, Chalajour F, Gehling UM, et al.: Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006; 133(8): 1543-51. PubMed Abstract | Publisher Full Text
142. Fleming JN, Nash RA, Mahoney WM Jr., et al.: Is scleroderma a vasculopathy? Curr Rheumatol Rep. 2009; 11(2): 103-10. PubMed Abstract | Publisher Full Text | Free Full Text
143. Muro AF, Moretti FA, Moore BB, et al.: An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med. 2008; 177(6): 638-45. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
144. Rönty MJ, Leivonen SK, Hinz B, et al.: Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Dermatol. 2006; 126(11): 2387-96. PubMed Abstract | Publisher Full Text | F1000 Recommendation
145. Schürch W, Seemayer TA, Lagacé R, et al.: The intermediate filament cytoskeleton of myofibroblasts: an immunofluorescence and ultrastructural study. Virchows Arch A Pathol Anat Histopathol. 1984; 403(4): 323-36. PubMed Abstract | Publisher Full Text
146. Skalli O, Schürch W, Seemayer T, et al.: Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989; 60(2): 275-85. PubMed Abstract
147. Kovanen PT, Tabas I: In search of a starting point. Curr Opin Lipidol. 2001; 12(5): 475-6. PubMed Abstract
148. Feil S, Fehrenbacher B, Lukowski R, et al.: Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res. 2014; 115(7): 662-7. PubMed Abstract | Publisher Full Text
149. Wang J, Uryga AK, Reinhold J, et al.: Vascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability. Circulation. 2015; 132(20): 1909-19. PubMed Abstract | Publisher Full Text
150. Doney MK, Gerken SC, Lynch R, et al.: Precise mapping of t(12;14) leiomyoma breakpoint on chromosome 14 between D14S298 and D14S540. Cancer Lett. 1995; 96(2): 245-52. PubMed Abstract | Publisher Full Text
151. Hayashi S, Miharu N, Okamoto E, et al.: Detection of chromosomal abnormalities in uterine leiomyoma using conventional cytogenetic method and interphase fluorescence in situ hybridization. Cancer Genet Cytogenet. 1996; 89(2): 98-104. PubMed Abstract | Publisher Full Text
152. Karaiskos C, Pandis N, Bardi G, et al.: Cytogenetic findings in uterine epithelioid leiomyomas. Cancer Genet Cytogenet. 1995; 80(2): 103-6. PubMed Abstract | Publisher Full Text
153. Matsuo H, Maruo T, Samoto T: Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab. 1997; 82(1): 293-9. PubMed Abstract | Publisher Full Text
154. Nilbert M, Rydholm A, Mitelman F, et al.: Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 1995; 83(1): 32-6. PubMed Abstract | Publisher Full Text
155. Sourla A, Polychronakos C, Zeng WR, et al.: Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Cancer Res. 1996; 56(13): 3123-8. PubMed Abstract
156. Valenti MT, Azzarello G, Vinante O, et al.: Differentiation, proliferation and apoptosis levels in human leiomyoma and leiomyosarcoma. J Cancer Res Clin Oncol. 1998; 124(2): 93-105. PubMed Abstract | Publisher Full Text
157. Van de Ven WJ, Schoenmakers EF, Wanschura S, et al.: Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer. 1995; 12(4): 296-303. PubMed Abstract | Publisher Full Text
158. Wanschura S, Hennig Y, Deichert U, et al.: Molecular-cytogenetic refinement of the 12q14-->q15 breakpoint region affected in uterine leiomyomas. Cytogenet Cell Genet. 1995; 71(2): 131-5. PubMed Abstract | Publisher Full Text
159. Krug EL, Rezaee M, Isokawa K, et al.: Transformation of cardiac endothelium into cushion mesenchyme is dependent on ES/130: Temporal, spatial, and functional studies in the early chick embryo. Cell Mol Biol Res. 1995; 41(4): 263-77. PubMed Abstract
160. Sugi Y, Markwald RR: Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol. 1996; 175(1): 66-83. PubMed Abstract | Publisher Full Text
161. Chappell D, Jacob M, Paul O, et al.: The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ Res. 2009; 104(11): 1313-7. PubMed Abstract | Publisher Full Text
162. Plein A, Fantin A, Denti L, et al.: Erythro-myeloid progenitors contribute endothelial cells to blood vessels. Nature. 2018; 562(7726): 223-8. PubMed Abstract | Publisher Full Text | F1000 Recommendation
163. Yang Q, Mas A, Diamond MP, et al.: The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Reprod Sci. 2016; 23(2): 163-75. PubMed Abstract | Publisher Full Text | Free Full Text
164. Majesky MW, Dong XR, Regan JN, et al.: Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ Res. 2011; 108(3): 365-77. PubMed Abstract | Publisher Full Text | Free Full Text
165. Lu J, Landerholm TE, Wei JS, et al.: Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol. 2001; 240(2): 404-18. PubMed Abstract | Publisher Full Text
166. Majesky MW: Vascular smooth muscle diversity: insights from developmental biology. Curr Atheroscler Rep. 2003; 5(3): 208-13. PubMed Abstract | Publisher Full Text
167. Majesky MW, Schwartz SM: Smooth muscle diversity in arterial wound repair. Toxicol Pathol. 1990; 18(4 Pt 1): 554-9. PubMed Abstract
168. Schwartz SM, Heimark RL, Majesky MW: Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990; 70(4): 1177-209. PubMed Abstract | Publisher Full Text
169. Topouzis S, Majesky MW: Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol. 1996; 178(2): 430-45. PubMed Abstract | Publisher Full Text
170. Mikawa T, Fischman DA: Retroviral analysis of cardiac morphogenesis: Discontinuous formation of coronary vessels. Proc Natl Acad Sci U S A. 1992; 89(20): 9504-8. PubMed Abstract | Publisher Full Text | Free Full Text
171. Flouris GA, Arvanitis DA, Parissis JT, et al.: Loss of heterozygosity in DNA mismatch repair genes in human atherosclerotic plaques. Mol Cell Biol Res Commun. 2000; 4(1): 62-5. PubMed Abstract | Publisher Full Text
172. Kiaris H, Hatzistamou J, Spandidos DA: Instability at the H-ras minisatellite in human atherosclerotic plaques. Atherosclerosis. 1996; 125(1): 47-51. PubMed Abstract | Publisher Full Text
173. Pearson TA, Dillman JM, Solez K, et al.: Clonal characteristics in layers of human atherosclerotic plaques. A study of the selection hypothesis of monoclonality. Am J Pathol. 1978; 93(1): 93-102. PubMed Abstract | Free Full Text
174. Pearson TA, Dillman JM, Solez K, et al.: Clonal characteristics of cutaneous scars and implications for atherogenesis. Am J Pathol. 1981; 102(1): 49-54. PubMed Abstract | Free Full Text
175. Pearson TA, Dillman J, Solez K, et al.: Monoclonal characteristics of organising arterial thrombi: Significance in the origin and growth of human atherosclerotic plaques. Lancet. 1979; 1(8106): 7-11. PubMed Abstract | Publisher Full Text
176. Schwartz SM, Murry CE: Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med. 1998; 49: 437-60. PubMed Abstract | Publisher Full Text
177. Wagner DE, Weinreb C, Collins ZM, et al.: Single-cell mapping of gene expression landscapes and lineage in the zebrafish embryo. Science. 2018; 360(6392): 981-7. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
178. Chung IM, et al: Monoclonality in atherosclerosis may arise by expansion of a pre-existing clone of smooth muscle cells. Circulation. 1996; 94(Suppl 1): 1-238.
179. Salipante SJ, Thompson JM, Horwitz MS: Phylogenetic fate mapping: theoretical and experimental studies applied to the development of mouse fibroblasts. Genetics. 2008; 178(2): 967-77. PubMed Abstract | Publisher Full Text | Free Full Text
180. Horwitz PA, Tsai EJ, Putt ME, et al.: Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation. 2004; 110(25): 3815-21. PubMed Abstract | Publisher Full Text
181. Risques RA, Kennedy SR: Aging and the rise of somatic cancer-associated mutations in normal tissues. PLoS Genet. 2018; 14(1): e1007108. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
182. Bedrosian TA, Quayle C, Novaresi N, et al.: Early life experience drives structural variation of neural genomes in mice. Science. 2018; 359(6382): 1395-9. PubMed Abstract | Publisher Full Text | F1000 Recommendation
183. Insel TR: Brain somatic mutations: the dark matter of psychiatric genetics? Mol Psychiatry. 2014; 19(2): 156-8. PubMed Abstract | Publisher Full Text
184. Paquola ACM, Erwin JA, Gage FH: Insights into the role of somatic mosaicism in the brain. Curr Opin Syst Biol. 2017; 1: 90-4. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
185. Andreassi MG, Botto N, Colombo MG, et al.: Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? Environ Mol Mutagen. 2000; 35(4): 265-9. PubMed Abstract
186. Ballinger SW, Patterson C, Knight-Lozano CA, et al.: Mitochondrial integrity and function in atherogenesis. Circulation. 2002; 106(5): 544-9. PubMed Abstract | Publisher Full Text
187. Bennett MR: Reactive oxygen species and death: oxidative DNA damage in atherosclerosis. Circ Res. 2001; 88(7): 648-50. PubMed Abstract | Publisher Full Text
188. Binková B, Smerhovský Z, Strejc P, et al.: DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res. 2002; 501(1-2): 115-28. PubMed Abstract | Publisher Full Text
189. Borgia MC, Mandolini C, Barresi C, et al.: Further evidence against the implication of active cytomegalovirus infection in vascular atherosclerotic diseases. Atherosclerosis. 2001; 157(2): 457-62. PubMed Abstract | Publisher Full Text
190. Botto N, Masetti S, Petrozzi L, et al.: Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002; 13(5): 269-74. PubMed Abstract | Publisher Full Text
191. Botto N, Rizza A, Colombo MG, et al.: Evidence for DNA damage in patients with coronary artery disease. Mutat Res. 2001; 493(1-2): 23-30. PubMed Abstract | Publisher Full Text
192. Chiu B: Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999; 138(5 Pt 2): S534-6. PubMed Abstract | Publisher Full Text
193. Clark KJ, Cary NR, Grace AA, et al.: Microsatellite mutation of type II transforming growth factor-beta receptor is rare in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001; 21(4): 555-9. PubMed Abstract | Publisher Full Text
194. Corral-Debrinski M, Shoffner JM, Lott MT, et al.: Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res. 1992; 275(3-6): 169-80. PubMed Abstract | Publisher Full Text
195. Fuster JJ, MacLauchlan S, Zuriaga MA, et al.: Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017; 355(6327): 842-847. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
196. Grati FR, Ghilardi G, Sirchia SM, et al.: Loss of heterozygosity of the NOS3 dinucleotide repeat marker in atherosclerotic plaques of human carotid arteries. Atherosclerosis. 2001; 159(2): 261-7. PubMed Abstract | Publisher Full Text
197. Hatzistamou J, Kiaris H, Ergazaki M, et al.: Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun. 1996; 225(1): 186-90. PubMed Abstract | Publisher Full Text
198. Hemnani T, Parihar MS: Reactive oxygen species and oxidative DNA damage. Indian J Physiol Pharmacol. 1998; 42(4): 440-52. PubMed Abstract
199. Hendrix MG, Daemen M, Bruggeman CA: Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol. 1991; 138(3): 563-7. PubMed Abstract | Free Full Text
200. Hendrix MG, Dormans PH, Kitslaar P, et al.: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 1989; 134(5): 1151-7. PubMed Abstract | Free Full Text
201. Horváth R, Cerný J, Benedík J Jr., et al.: The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000; 16(1): 17-24. PubMed Abstract | Publisher Full Text
202. Izzotti A, Cartiglia C, Lewtas J, et al.: Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 2001; 15(3): 752-7. PubMed Abstract | Publisher Full Text
203. Kreja L, Finking G: Development of an in vitro model to study oxidative DNA damage in human coronary smooth muscle cells. ALTEX. 2002; 19(3): 123-9. PubMed Abstract
204. Liao S, Curci JA, Kelley BJ, et al.: Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms compared to the adjacent inferior mesenteric artery. J Surg Res. 2000; 92(1): 85-95. PubMed Abstract | Publisher Full Text
205. Martinet W, Knaapen MW, De Meyer GR, et al.: Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res. 2001; 88(7): 733-9. PubMed Abstract | Publisher Full Text
206. Martinet W, Knaapen MW, De Meyer GR, et al.: Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 2002; 106(8): 927-32. PubMed Abstract | Publisher Full Text | F1000 Recommendation
207. Melnick JL, Adam E, DeBakey ME: Cytomegalovirus and atherosclerosis. Arch Immunol Ther Exp (Warsz). 1996; 44(5-6): 297-302. PubMed Abstract
208. Miniati P, Sourvinos G, Michalodimitrakis M, et al.: Loss of heterozygosity on chromosomes 1, 2, 8, 9 and 17 in cerebral atherosclerotic plaques. Int J Biol Markers. 2001; 16(3): 167-71. PubMed Abstract | Publisher Full Text
209. Olinski R, Gackowski D, Foksinski M, et al.: Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med. 2002; 33(2): 192-200. PubMed Abstract | Publisher Full Text
210. Parkes JL, Cardell RR, Hubbard FC Jr., et al.: Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol. 1991; 138(3): 765-75. PubMed Abstract | Free Full Text
211. Saetta A, Fanourakis G, Agapitos E, et al.: Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol. 2000; 9(3): 181-3. PubMed Abstract | Publisher Full Text
212. Shi Y, Tokunaga O: Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int. 2002; 52(1): 31-9. PubMed Abstract | Publisher Full Text
213. Spandidos DA, Ergazaki M, Arvanitis D, et al.: Microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun. 1996; 220(1): 137-40. PubMed Abstract | Publisher Full Text
214. Weakley SM, Jiang J, Kougias P, et al.: Role of somatic mutations in vascular disease formation. Expert Rev Mol Diagn. 2010; 10(2): 173-85. PubMed Abstract | Publisher Full Text | Free Full Text
215. Yamashiroya HM, Ghosh L, Yang R, et al.: Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 1988; 130(1): 71-9. PubMed Abstract | Free Full Text
216. Zhou YF, Shou M, Guetta E, et al.: Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999; 100(14): 1569-75. PubMed Abstract | Publisher Full Text
217. Ando K, Nakajima Y, Yamagishi T, et al.: Development of proximal coronary arteries in quail embryonic heart: multiple capillaries penetrating the aortic sinus fuse to form main coronary trunk. Circ Res. 2004; 94(3): 346-52. PubMed Abstract | Publisher Full Text
218. Baek ST, Tallquist MD: Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation. Development. 2012; 139(11): 2040-9. PubMed Abstract | Publisher Full Text | Free Full Text
219. Brewer CM, Majesky MW: Branch Point Smooth Muscle Cells Highlighted by Novel Lineage Tracking Approach. Circ Res. 2018; 122(2): 194-6. PubMed Abstract | Publisher Full Text | Free Full Text
220. Cooley BC, Nevado J, Mellad J, et al.: TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med. 2014; 6(227): 227ra34. PubMed Abstract | Publisher Full Text | Free Full Text
221. Liu AC, Joag VR, Gotlieb AI: The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007; 171(5): 1407-18. PubMed Abstract | Publisher Full Text | Free Full Text
222. Majesky MW: Development of coronary vessels. Curr Top Dev Biol. 2004; 62: 225-59. PubMed Abstract | Publisher Full Text
223. Majesky MW: Adventitia and perivascular cells. Arterioscler Thromb Vasc Biol. 2015; 35(8): e31-5. PubMed Abstract | Publisher Full Text | Free Full Text
224. Majesky MW, Horita H, Ostriker A, et al.: Differentiated Smooth Muscle Cells Generate a Subpopulation of Resident Vascular Progenitor Cells in the Adventitia Regulated by Klf4. Circ Res. 2017; 120(2): 296-311. PubMed Abstract | Publisher Full Text | Free Full Text
225. Majesky MW, Schwartz SM: An origin for smooth muscle cells from endothelium? Circ Res. 1997; 80(4): 601-3. PubMed Abstract
226. Roostalu U, Wong JK: Arterial smooth muscle dynamics in development and repair. Dev Biol. 2018; 435(2): 109-21. PubMed Abstract | Publisher Full Text | F1000 Recommendation
227. Sawada H, Rateri DL, Moorleghen JJ, et al.: Smooth Muscle Cells Derived From Second Heart Field and Cardiac Neural Crest Reside in Spatially Distinct Domains in the Media of the Ascending Aorta-Brief Report. Arterioscler Thromb Vasc Biol. 2017; 37(9): 1722-6. PubMed Abstract | Publisher Full Text | Free Full Text
228. Souilhol C, Harmsen MC, Evans PC, et al.: Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018; 114(4): 565-77. PubMed Abstract | Publisher Full Text | F1000 Recommendation
229. Yoshida T, Gan Q, Franke AS, et al.: Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem. 2010; 285(27): 21175-84. PubMed Abstract | Publisher Full Text | Free Full Text
230. Wang JC, Bennett M: Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012; 111(2): 245-59. PubMed Abstract | Publisher Full Text
231. Desai P, Mencia-Trinchant N, Savenkov O, et al.: Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med. 2018; 24(7): 1015-23. PubMed Abstract | Publisher Full Text | F1000 Recommendation
232. Stemme S, Faber B, Holm J, et al.: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995; 92(9): 3893-7. PubMed Abstract | Publisher Full Text | Free Full Text
233. Konstantinov IE: In search of Alexander A. Maximow: the man behind the unitarian theory of hematopoiesis. Perspect Biol Med. 2000; 43(2): 269-76. PubMed Abstract | Publisher Full Text
234. Maximov AA, Bloom W: A Textbook of Histology. Philadelphia: W.B. Saunders. 1930. Reference Source
235. Horvitz HR, Sulston JE: “Joy of the worm”. Genetics. 1990; 126(2): 287-92. PubMed Abstract | Free Full Text
236. Garcia-Ojalvo J: Cell Lineage Trees Bear Fruit. Cell Syst. 2016; 3(6): 511-3. PubMed Abstract | Publisher Full Text
237. Silver GA: Virchow, the heroic model in medicine: health policy by accolade. Am J Public Health. 1987; 77(1): 82-8. PubMed Abstract | Publisher Full Text | Free Full Text
238. Waddington CH: The strategy of the genes: a discussion of some aspects of theoretical biology. London: Allen & Unwin. 1957. Reference Source
239. Trapnell C: Defining cell types and states with single-cell genomics. Genome Res. 2015; 25(10): 1491-8. PubMed Abstract | Publisher Full Text | Free Full Text
240. Link VM, Duttke SH, Chun HB, et al.: Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function. Cell. 2018; 173(7): 1796-1809.e17. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
241. Fonseca GJ, Seidman JS, Glass CK: Genome-Wide Approaches to Defining Macrophage Identity and Function. Microbiol Spectr. 2016; 4(5). PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
242. Gomez Perdiguero E, Klapproth K, Schulz C, et al.: Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015; 518(7540): 547-51. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
243. Perdiguero EG, Geissmann F: The development and maintenance of resident macrophages. Nat Immunol. 2016; 17(1): 2-8. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
244. Schulz C, Gomez Perdiguero E, Chorro L, et al.: A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012; 336(6077): 86-90. PubMed Abstract | Publisher Full Text | F1000 Recommendation
245. Varol C, Landsman L, Fogg DK, et al.: Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med. 2007; 204(1): 171-80. PubMed Abstract | Publisher Full Text | Free Full Text
246. Wlodarczyk A, Holtman IR, Krueger M, et al.: A novel microglial subset plays a key role in myelinogenesis in developing brain. EMBO J. 2017; 36(22): 3292-308. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
247. Woollard KJ, Geissmann F: Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010; 7(2): 77-86. PubMed Abstract | Publisher Full Text | Free Full Text
248. Moss NS, Benditt EP: Spontaneous and experimentally induced arterial lesions. I. An ultrastructural survey of the normal chicken aorta. Lab Invest. 1970; 22(2): 166-83. PubMed Abstract
249. Dong J, Horvath S: Understanding network concepts in modules. BMC Syst Biol. 2007; 1: 24. PubMed Abstract | Publisher Full Text | Free Full Text
250. Langfelder P, Luo R, Oldham MC, et al.: Is my network module preserved and reproducible? PLoS Comput Biol. 2011; 7(1): e1001057. PubMed Abstract | Publisher Full Text | Free Full Text
251. Song L, Langfelder P, Horvath S: Comparison of co-expression measures: mutual information, correlation, and model based indices. BMC Bioinformatics. 2012; 13: 328. PubMed Abstract | Publisher Full Text | Free Full Text
252. Mason MJ, Fan G, Plath K, et al.: Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics. 2009; 10: 327. PubMed Abstract | Publisher Full Text | Free Full Text
253. Subramanian A, Narayan R, Corsello SM, et al.: A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell. 2017; 171(6): 1437-1452.e17. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
254. Aten JE, Fuller TF, Lusis AJ, et al.: Using genetic markers to orient the edges in quantitative trait networks: the NEO software. BMC Syst Biol. 2008; 2: 34. PubMed Abstract | Publisher Full Text | Free Full Text
255. Lee SI, Dudley AM, Drubin D, et al.: Learning a prior on regulatory potential from eQTL data. PLoS Genet. 2009; 5(1): e1000358. PubMed Abstract | Publisher Full Text | Free Full Text
256. Lee SI, Pe'er D, Dudley AM, et al.: Identifying regulatory mechanisms using individual variation reveals key role for chromatin modification. Proc Natl Acad Sci U S A. 2006; 103(38): 14062-7. PubMed Abstract | Publisher Full Text | Free Full Text
257. Li H, Chen H, Bao L, et al.: Integrative genetic analysis of transcription modules: towards filling the gap between genetic loci and inherited traits. Hum Mol Genet. 2006; 15(3): 481-92. PubMed Abstract | Publisher Full Text
258. Schwartz SM, Schwartz HT, Horvath S, et al.: A systematic approach to multifactorial cardiovascular disease: causal analysis. Arterioscler Thromb Vasc Biol. 2012; 32(12): 2821-35. PubMed Abstract | Publisher Full Text
259. Cao J, Packer JS, Ramani V, et al.: Comprehensive single-cell transcriptional profiling of a multicellular organism. Science. 2017; 357(6352): 661-7. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
260. Cusanovich DA, Reddington JP, Garfield DA, et al.: The cis-regulatory dynamics of embryonic development at single-cell resolution. Nature. 2018; 555(7697): 538-42. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
261. Drake TA, Schadt EE, Lusis AJ: Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice. Mamm Genome. 2006; 17(6): 466-79. PubMed Abstract | Publisher Full Text | Free Full Text
262. Schadt EE: Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits. Curr Opin Biotechnol. 2005; 16(6): 647-54. PubMed Abstract | Publisher Full Text
263. Schadt EE: Association Studies: A genome-wide association approach to mapping the genetic determinants of the transcriptome in human populations. Eur J Hum Genet. 2006; 14: 891-3. Publisher Full Text
264. Campbell GR, Campbell JH, Manderson JA, et al.: Arterial smooth muscle. A multifunctional mesenchymal cell. Arch Pathol Lab Med. 1988; 112(10): 977-86. PubMed Abstract
265. Chamley JH, Campbell GR, Burnstock G: Dedifferentiation, redifferentiation and bundle formation of smooth muscle cells in tissue culture: the influence of cell number and nerve fibres. J Embryol Exp Morphol. 1974; 32(2): 297-323. PubMed Abstract
266. Du KL, Ip HS, Li J, et al.: Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol. 2003; 23(7): 2425-37. PubMed Abstract | Publisher Full Text | Free Full Text
267. Gan Q, Yoshida T, Li J, et al.: Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res. 2007; 101(9): 883-92. PubMed Abstract | Publisher Full Text | F1000 Recommendation
268. Hautmann MB, Adam PJ, Owens GK: Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999; 19(9): 2049-58. PubMed Abstract | Publisher Full Text
269. Jin L, Yoshida T, Ho R, et al.: The actin-associated protein Palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem. 2009; 284(4): 2121-30. PubMed Abstract | Publisher Full Text | Free Full Text
270. Kumar MS, Owens GK: Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol. 2003; 23(5): 737-47. PubMed Abstract | Publisher Full Text
271. Mack CP, Thompson MM, Lawrenz-Smith S, et al.: Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res. 2000; 86(2): 221-32. PubMed Abstract | Publisher Full Text
272. Manabe I, Owens GK: CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest. 2001; 107(7): 823-34. PubMed Abstract | Publisher Full Text | Free Full Text
273. Manabe I, Owens GK: Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ Res. 2001; 88(11): 1127-34. PubMed Abstract | Publisher Full Text
274. Owens GK: Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand. 1998; 164(4): 623-35. PubMed Abstract | Publisher Full Text
275. Yoshida T, Owens GK: Molecular determinants of vascular smooth muscle cell diversity. Circ Res. 2005; 96(3): 280-91. PubMed Abstract | Publisher Full Text
276. Price DL, Porter KR: The response of ventral horn neurons to axonal transection. J Cell Biol. 1972; 53(1): 24-37. PubMed Abstract | Publisher Full Text | Free Full Text
277. Tapscott SJ, Lassar AB, Davis RL, et al.: 5-bromo-2’-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science. 1989; 245(4917): 532-6. PubMed Abstract | Publisher Full Text
278. Bochaton-Piallat ML, Gabbiani F, Redard M, et al.: Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995; 146(5): 1059-64. PubMed Abstract | Free Full Text
279. Guelfi S, Duffau H, Bauchet L, et al.: Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells. Stem Cells Int. 2016; 2016: 2759403. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
280. Glass CK: Genetic and genomic approaches to understanding macrophage identity and function. Arterioscler Thromb Vasc Biol. 2015; 35(4): 755-62. PubMed Abstract | Publisher Full Text | Free Full Text
281. Belknap JK, Grieshaber NA, Schwartz PE, et al.: Tropoelastin gene expression in individual vascular smooth muscle cells. Relationship to DNA synthesis during vascular development and after arterial injury. Circ Res. 1996; 78(3): 388-94. PubMed Abstract | Publisher Full Text
282. Bergwerff M, DeRuiter MC, Poelmann RE, et al.: Onset of elastogenesis and downregulation of smooth muscle actin as distinguishing phenomena in artery differentiation in the chick embryo. Anat Embryol (Berl). 1996; 194(6): 545-57. PubMed Abstract | Publisher Full Text
283. Gadson PF Jr., Rossignol C, McCoy J, et al.: Expression of elastin, smooth muscle alpha-actin, and c-jun as a function of the embryonic lineage of vascular smooth muscle cells. In Vitro Cell Dev Biol Anim. 1993; 29A(10): 773-81. PubMed Abstract | Publisher Full Text
284. Lemire JM, Potter-Perigo S, Hall KL, et al.: Distinct rat aortic smooth muscle cells differ in versican/PG-M expression. Arterioscler Thromb Vasc Biol. 1996; 16(6): 821-9. PubMed Abstract | Publisher Full Text
285. Thyberg J: Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol. 1996; 169: 183-265. PubMed Abstract | Publisher Full Text
286. Red-Horse K, Ueno H, Weissman IL, et al.: Coronary arteries form by developmental reprogramming of venous cells. Nature. 2010; 464(7288): 549-53. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
287. Marcu R, Choi YJ, Xue J, et al.: Human Organ-Specific Endothelial Cell Heterogeneity. iScience. 2018; 4: 20-35. PubMed Abstract | Publisher Full Text | Free Full Text
288. Nolan DJ, Ginsberg M, Israely E, et al.: Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell. 2013; 26(2): 204-19. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
289. Cunha GR, Hayward SW, Dahiya R, et al.: Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat (Basel). 1996; 155(1): 63-72. PubMed Abstract | Publisher Full Text
290. Cunha GR, Young P, Hamamoto S, et al.: Developmental response of adult mammary epithelial cells to various fetal and neonatal mesenchymes. Epithelial Cell Biol. 1992; 1(3): 105-18. PubMed Abstract
291. DiSandro MJ, Li Y, Baskin LS, et al.: Mesenchymal-epithelial interactions in bladder smooth muscle development: Epithelial specificity. J Urol. 1998; 160(3 Pt 2): 1040-6; discussion 1079. PubMed Abstract | Publisher Full Text
292. Caplice NM, Bunch TJ, Stalboerger PG, et al.: Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 2003; 100(8): 4754-9. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
293. Sata M, Saiura A, Kunisato A, et al.: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8(4): 403-9. PubMed Abstract | Publisher Full Text
294. Bentzon JF, Weile C, Sondergaard CS, et al.: Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2006; 26(12): 2696-702. PubMed Abstract | Publisher Full Text | F1000 Recommendation
295. Holifield B, Helgason T, Jemelka S, et al.: Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996; 97(3): 814-25. PubMed Abstract | Publisher Full Text | Free Full Text
296. Scott NA, Cipolla GD, Ross CE, et al.: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996; 93(12): 2178-87. PubMed Abstract | Publisher Full Text
297. Coen M, Gabbiani G, Bochaton-Piallat ML: Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol. 2011; 31(11): 2391-6. PubMed Abstract | Publisher Full Text
298. Davis J, Molkentin JD: Myofibroblasts: Trust your heart and let fate decide. J Mol Cell Cardiol. 2014; 70: 9-18. PubMed Abstract | Publisher Full Text | Free Full Text
299. Kaneishi NK, Cockerell CJ: Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol. 1998; 20(2): 128-34. PubMed Abstract | Publisher Full Text
300. Otranto M, Sarrazy V, Bonté F, et al.: The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr. 2012; 6(3): 203-19. PubMed Abstract | Publisher Full Text | Free Full Text
301. Walker RA: The complexities of breast cancer desmoplasia. Breast Cancer Res. 2001; 3(3): 143-5. PubMed Abstract | Publisher Full Text | Free Full Text
302. Volz KS, Jacobs AH, Chen HI, et al.: Pericytes are progenitors for coronary artery smooth muscle. eLife. 2015; 4: pii: e10036. PubMed Abstract | Publisher Full Text | Free Full Text
303. Majesky MW, Dong XR, Hoglund V, et al.: The adventitia: a progenitor cell niche for the vessel wall. Cells Tissues Organs. 2012; 195(1-2): 73-81. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
304. DeRuiter MC, Poelmann RE, VanMunsteren JC, et al.: Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 1997; 80(4): 444-51. PubMed Abstract | Publisher Full Text
305. Morimoto M, Liu Z, Cheng HT, et al.: Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 2010; 123(Pt 2): 213-24. PubMed Abstract | Publisher Full Text | Free Full Text
306. Suzuki T, Carrier EJ, Talati MH, et al.: Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2018; 314(1): L118-L126. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
307. Nakajima Y, Mironov V, Yamagishi T, et al.: Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: a role for transforming growth factor beta3. Dev Dyn. 1997; 209(3): 296-309. PubMed Abstract | Publisher Full Text
308. Chang L, Noseda M, Higginson M, et al.: Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling. Proc Natl Acad Sci U S A. 2012; 109(18): 6993-8. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
309. Arribas SM, Briones AM, Bellingham C, et al.: Heightened aberrant deposition of hard-wearing elastin in conduit arteries of prehypertensive SHR is associated with increased stiffness and inward remodeling. Am J Physiol Heart Circ Physiol. 2008; 295(6): H2299-307. PubMed Abstract | Publisher Full Text
310. Wong LC, Langille BL: Developmental remodeling of the internal elastic lamina of rabbit arteries: effect of blood flow. Circ Res. 1996; 78(5): 799-805. PubMed Abstract | Publisher Full Text
311. Lu YW, Lowery AM, Sun LY, et al.: Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina. Arterioscler Thromb Vasc Biol. 2017; 37(7): 1380-90. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
312. Baeyens N, Bandyopadhyay C, Coon BG, et al.: Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest. 2016; 126(3): 821-8. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
313. Rao RN, Falls DG, Gerrity RG, et al.: Intimal thickness and layering, and smooth muscle cell phenotypes in aorta of youth. Pathobiology. 2000; 68(1): 18-28. PubMed Abstract | Publisher Full Text
314. Williams KJ, Tabas I: Lipoprotein retention--and clues for atheroma regression. Arterioscler Thromb Vasc Biol. 2005; 25(8): 1536-40. PubMed Abstract | Publisher Full Text
315. Trigueros-Motos L, González-Granado JM, Cheung C, et al.: Embryological-origin-dependent differences in homeobox expression in adult aorta: role in regional phenotypic variability and regulation of NF-κB activity. Arterioscler Thromb Vasc Biol. 2013; 33(6): 1248-56. PubMed Abstract | Publisher Full Text
316. Jin H, Li DY, Chernogubova E, et al.: Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions. Mol Ther. 2018; 26(4): 1040-55. PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation
317. Karnik SK, Brooke BS, Bayes-Genis A, et al.: A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2003; 130(2): 411-23. PubMed Abstract | Publisher Full Text
318. Li DY, Faury G, Taylor DG, et al.: Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest. 1998; 102(10): 1783-7. PubMed Abstract | Publisher Full Text | Free Full Text
319. Li DY, Brooke B, Davis EC, et al.: Elastin is an essential determinant of arterial morphogenesis. Nature. 1998; 393(6682): 276-80. PubMed Abstract | Publisher Full Text
320. Van Brussel I, Ammi R, Rombouts M, et al.: Fluorescent activated cell sorting: an effective approach to study dendritic cell subsets in human atherosclerotic plaques. J Immunol Methods. 2015; 417: 76-85. PubMed Abstract | Publisher Full Text